Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study-Reference-Cited by-同舟云学术

Weekly paclitaxel in combination with carboplatin for advanced non-small-cell lung cancer complicated by idiopathic interstitial pneumonias: a single-arm phase II study

Published:2019-07-27 Issue:12 Volume:24 Page:1543-1548
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Fukuizumi Aya,Minegishi Yuji,Omori Miwako,Atsumi Kenichiro,Takano Natsuki,Hisakane Kakeru,Takahashi Satoshi,Kobayashi Kenichi,Sugano Teppei,Takeuchi Susumu,Noro Rintaro,Seike Masahiro,Kubota Kaoru,Azuma Arata,Gemma Akihiko

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/content/pdf/10.1007/s10147-019-01516-9.pdf

Reference26 articles.

1. Hubbard R, Venn A, Lewis S et al (2000) Lung cancer and cryptogenic fibrosing alveolitis. Population-based cohort study. Am J Respir Crit Care Med 161:5–8

2. Turner-Warwick M, Lebowits M, Burrows B et al (1980) Cryptogenic fibrosing alveolitis and lung cancer. Thorax 35:496–499

3. Panos RJ, Mortenson RL, Niccoli SA et al (1990) Clinical deterioration in patients with idiopathic pulmonary fibrosis: caused and assessment. Am J Med 88:396–404

4. Park J, Kim DS, Shim TS et al (2001) Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 17:1216–1219

5. American Thoracic Society/European Respiratory Society (2002) International multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute exacerbation predicting poor outcomes in idiopathic interstitial pneumonia and advanced lung cancer patients undergoing cytotoxic chemotherapy;Scientific Reports;2024-05-03

2. Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition;Respiratory Investigation;2024-05

3. Treatment Strategies for Non-Small-Cell Lung Cancer with Comorbid Respiratory Disease; Interstitial Pneumonia, Chronic Obstructive Pulmonary Disease, and Tuberculosis;Cancers;2024-04-29

4. Nintedanib plus Chemotherapy for Small Cell Lung Cancer with Comorbid Idiopathic Pulmonary Fibrosis;Annals of the American Thoracic Society;2024-04

5. Current pharmacotherapies for advanced lung cancer with pre-existing interstitial lung disease : A literature review and future perspectives;The Journal of Medical Investigation;2024